Jove
Visualize
Contact Us

Related Concept Videos

Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Incident Stroke in the United States and Foreign Born Black Individuals.

Neurology·2026
Same journal

Prenatal Brain MRI Manifestations of <i>TSC2/PKD1</i> Contiguous Gene Deletion Syndrome in a Fetus.

Neurology·2026
Same journal

Two-Year Retention of Benefits After Paired Vagus Nerve Stimulation in Stroke: Follow-Up of the VNS-REHAB Randomized Clinical Trial.

Neurology·2026
Same journal

Legal Protections to Mitigate Discrimination due to Neurodegenerative Biomarker Status.

Neurology·2026
Same journal

Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.

Neurology·2026
Same journal

Plasma P-Tau217: A Powerful Alzheimer Disease Biomarker in the Right Clinical Context.

Neurology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 17, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Using tPA for acute stroke in a rural setting.

Lorraine L Edwards1

  • 1Central Nebraska Neurology, 2727 W. 2nd Street, Suite 340, Hastings, NE 68901, USA. centralnn@alltel.net

Neurology
|January 24, 2007
PubMed
Summary

Intravenous tissue plasminogen activator (tPA) is safe and effective for acute stroke treatment, even in small rural hospitals. This study found zero mortality and no symptomatic intracranial hemorrhage in patients receiving tPA.

More Related Videos

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Related Experiment Videos

Last Updated: Jul 17, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Area of Science:

  • Neurology
  • Emergency Medicine
  • Pharmacology

Background:

  • The use of tissue plasminogen activator (tPA) for acute stroke treatment remains controversial, particularly in non-major medical centers.
  • Limited data exists on the safety and efficacy of tPA in smaller, rural hospital settings.

Purpose of the Study:

  • To evaluate the safety and efficacy of intravenous tPA in treating acute ischemic stroke and transient ischemic attack (TIA) patients at a small rural hospital.
  • To assess the incidence of symptomatic intracranial hemorrhage and mortality rates associated with tPA administration in this setting.

Main Methods:

  • A retrospective chart review was conducted for 493 patients admitted with TIA or stroke between 1998 and 2004.
  • Data collected included tPA treatment rates, symptomatic intracranial hemorrhage, and mortality.

Main Results:

  • A 4% tPA treatment rate was observed among eligible patients.
  • No cases of symptomatic intracranial hemorrhage were reported.
  • Zero mortality was recorded for patients treated with tPA.

Conclusions:

  • Intravenous tPA can be administered safely and effectively for acute stroke treatment, irrespective of hospital size.
  • These findings support the use of tPA in rural hospitals, challenging previous concerns about its application outside major centers.